Clofazimine Contributes Sustained Antimicrobial Activity after Treatment Cessation in a Mouse Model of Tuberculosis Chemotherapy. (Q36888058)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26926638%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

Clofazimine Contributes Sustained Antimicrobial Activity after Treatment Cessation in a Mouse Model of Tuberculosis Chemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26926638%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26926638%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Nicole C Ammerman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26926638%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Linda A. Bester

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26926638%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

12

Jacques H Grosset

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26926638%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Bongani Ngcobo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26926638%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

John Adamson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26926638%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Chivonne Moodley

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26926638%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Afton Dorasamy

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26926638%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Sashen Moodley

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26926638%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Zinhle Mgaga

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26926638%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Sanil D Singh

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26926638%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Deepak V Almeida

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26926638%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

language of work or name

English

0 references

publication date

22 April 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26926638%20AND%20SRC:MED&resulttype=core&format=json

Antimicrobial Agents and Chemotherapy

9 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26926638%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26926638%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26926638%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

2864-2869

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26926638%20AND%20SRC:MED&resulttype=core&format=json

High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon

9 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862514

Pharmacokinetics and pharmacodynamics of clofazimine in a mouse model of tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862514

Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862514

Successful '9-month Bangladesh regimen' for multidrug-resistant tuberculosis among over 500 consecutive patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862514

Assessment of clofazimine activity in a second-line regimen for tuberculosis in mice.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862514

Multiscale distribution and bioaccumulation analysis of clofazimine reveals a massive immune system-mediated xenobiotic sequestration response

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862514

Macrophages sequester clofazimine in an intracellular liquid crystal-like supramolecular organization

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862514

World Health Organization group 5 drugs for the treatment of drug-resistant tuberculosis: unclear efficacy or untapped potential?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862514

Sterilizing activities of novel combinations lacking first- and second-line drugs in a murine model of tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862514

Sterilizing activity of novel TMC207- and PA-824-containing regimens in a murine model of tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862514

Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862514

Electron microscope studies of the antileprosy drug B663 (clofazimine; Lamprenel).

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862514

Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862514

Bioavailability of rifampin in experimental murine tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862514

Compassionate use of bedaquiline for the treatment of multidrug-resistant and extensively drug-resistant tuberculosis: interim analysis of a French cohort

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862514

High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862514

Tissue concentrations of clofazimine (B663) in man.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862514

Some observations on the pharmacology of clofazimine (B663).

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862514

Identification of crystals of the rimino-phenazine compound B663 (lamprene: Clofazimine) in mouse spleen macrophages by thin layer chromatography and mass spectrum analysis

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862514

Clofazimine for the treatment of multidrug-resistant tuberculosis: prospective, multicenter, randomized controlled study in China

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4862514

[Experimental antituberculous activity of 2 derivatives of pigmented phenazine (B 663 and B 720) alone and combined with other antitubercular agents (Isoniazid and ethoniamide).]

4 September 2018

1 reference

12 December 2020

Antituberculosis activity in the phenazine series; isomeric pigments obtained by oxidation of o-phenylenediamine derivatives

1 reference

12 December 2020

A New Series of Phenazines (Rimino-Compounds) With High Antituberculosis Activity

1 reference

12 December 2020

Pharmacologic Studies of Clofazimine *

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.00177-16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26926638%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26926638%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

PubMed publication ID

26926638

1 reference